Ingredient guide · Ingredient reference

Does melatonin cross the blood-brain barrier?

Yes, melatonin can cross the blood-brain barrier. That property helps explain why it is studied for brain-related effects, but it does not establish that a supplement prevents dementia, repairs the barrier or treats a neurological disease. Brain access and proven clinical benefit are separate questions.

Read the evidence ↓

Supplement Science Insights Editorial Team

Published September 23, 2026

Its chemistry permits membrane passage

The reviewed literature describes melatonin as amphiphilic, with properties that allow movement across cellular membranes, including the blood-brain barrier. This is different from assuming that every substance labeled an antioxidant reaches brain tissue in the same way. [1]

Receptor and nonreceptor effects are both studied

Endotext describes MT1 and MT2 receptor signaling as well as nonreceptor-mediated actions. These help explain biological activity, but the concentration, timing and tissue context determine the response. Crossing a barrier does not specify the amount needed for a clinical outcome. [2]

Neuroprotection remains a separate evidence problem

Mechanistic reviews discuss oxidative stress, mitochondria and inflammation, often using experimental models. The recent review also notes small clinical groups and the need for larger, well-designed studies. Those limitations prevent treating brain penetration as proof of disease prevention. [1]

Avoid a dose inference from a transport fact

Imagine an advertisement says a large dose must protect the brain because melatonin enters it. The conclusion does not follow. Use melatonin only for an appropriate purpose with attention to adverse effects and interactions, rather than escalating it to chase an unproven neurological benefit. [3][1]

Hypothetical example — separate transport from treatment
FindingWhat remains unknown
Crosses the barrierEffective dose for a disease
Acts on receptorsIndividual clinical response
Antioxidant mechanismLong-term neurological benefit
Higher exposureNot automatically better protection
Does melatonin cross the blood-brain barrier? — original article outline diagram
Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

Sources for this article

  1. Melatonin—A Powerful Antioxidant in Neurodegenerative Diseases - PMC
    Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.
  2. Physiology of the Pineal Gland and Melatonin - Endotext - NCBI Bookshelf
    Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.
  3. Melatonin: What You Need To Know | NCCIH
    Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.